Patricia A Ganz1, Erin E Hahn2, Laura Petersen2, Michelle E Melisko3, John P Pierce4, Marlene Von Friederichs-Fitzwater5, Karen T Lane6, Robert A Hiatt3. 1. Jonsson Comprehensive Cancer Center, University of California, Los Angeles, CA. Electronic address: pganz@mednet.ucla.edu. 2. Jonsson Comprehensive Cancer Center, University of California, Los Angeles, CA. 3. Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA. 4. Moores Cancer Center, University of California, San Diego, CA. 5. UC Davis Comprehensive Cancer Center, University of California, Davis, CA. 6. Chao Family Comprehensive Cancer Center, University of California, Irvine, CA.
Abstract
INTRODUCTION: Multiple oncology providers are involved in the initial breast cancer treatment. To better understand the patterns and quality of posttreatment breast cancer care, we surveyed patients who had been treated at each of the 5 University of California (UC) cancer centers. PATIENTS AND METHODS: We identified breast cancer patients diagnosed in 2008-2009 from hospital tumor registries; invitations for the mailed survey on posttreatment care were sent between September 2011 and November 2012. The survey requested information on the number and type of provider visits, discussion of key topics, use of treatment summaries, and survivorship care plans (SCP). RESULTS: A total of 329 patients completed the survey. The mean age of respondents was 60.5 years, and they were 3.2 years since diagnosis (range, 1.6-4.8 years). A total of 82% had continued posttreatment care at a UC facility, and they reported high numbers of clinical follow-up visits, with an average of > 2 providers (range, 1-5). Surgery-only patients reported an average of 4 to 5 office visits a year; patients who received surgery, radiation, and chemotherapy reported 5 to 6 office visits a year. Overall, 45% of women reported receiving a treatment summary; receipt of a SCP was reported by 59%, occurring significantly more often among those in follow-up at a UC (P = .004). CONCLUSION: Patients reported visits to multiple providers during their follow-up care, in excess of what is recommended by current guidelines. This was in spite of many women reporting that they had received a SCP.
INTRODUCTION: Multiple oncology providers are involved in the initial breast cancer treatment. To better understand the patterns and quality of posttreatment breast cancer care, we surveyed patients who had been treated at each of the 5 University of California (UC) cancer centers. PATIENTS AND METHODS: We identified breast cancerpatients diagnosed in 2008-2009 from hospital tumor registries; invitations for the mailed survey on posttreatment care were sent between September 2011 and November 2012. The survey requested information on the number and type of provider visits, discussion of key topics, use of treatment summaries, and survivorship care plans (SCP). RESULTS: A total of 329 patients completed the survey. The mean age of respondents was 60.5 years, and they were 3.2 years since diagnosis (range, 1.6-4.8 years). A total of 82% had continued posttreatment care at a UC facility, and they reported high numbers of clinical follow-up visits, with an average of > 2 providers (range, 1-5). Surgery-only patients reported an average of 4 to 5 office visits a year; patients who received surgery, radiation, and chemotherapy reported 5 to 6 office visits a year. Overall, 45% of women reported receiving a treatment summary; receipt of a SCP was reported by 59%, occurring significantly more often among those in follow-up at a UC (P = .004). CONCLUSION:Patients reported visits to multiple providers during their follow-up care, in excess of what is recommended by current guidelines. This was in spite of many women reporting that they had received a SCP.
Authors: James L Khatcheressian; Antonio C Wolff; Thomas J Smith; Eva Grunfeld; Hyman B Muss; Victor G Vogel; Francine Halberg; Mark R Somerfield; Nancy E Davidson Journal: J Clin Oncol Date: 2006-10-10 Impact factor: 44.544
Authors: Jeanne S Mandelblatt; William F Lawrence; Jennifer Cullen; Annette L Stanton; Janice L Krupnick; Lorna Kwan; Patricia A Ganz Journal: J Clin Oncol Date: 2006-01-01 Impact factor: 44.544
Authors: Erin E Hahn; Patricia A Ganz; Michelle E Melisko; John P Pierce; Marlene von Friederichs-Fitzwater; Karen T Lane; Robert A Hiatt Journal: J Cancer Surviv Date: 2013-03-15 Impact factor: 4.442
Authors: Benjamin D Smith; Grace L Smith; Arti Hurria; Gabriel N Hortobagyi; Thomas A Buchholz Journal: J Clin Oncol Date: 2009-04-29 Impact factor: 44.544
Authors: James L Khatcheressian; Patricia Hurley; Elissa Bantug; Laura J Esserman; Eva Grunfeld; Francine Halberg; Alexander Hantel; N Lynn Henry; Hyman B Muss; Thomas J Smith; Victor G Vogel; Antonio C Wolff; Mark R Somerfield; Nancy E Davidson Journal: J Clin Oncol Date: 2012-11-05 Impact factor: 44.544
Authors: J L Tucholka; N Jacobson; N M Steffens; J R Schumacher; A J Tevaarwerk; B Anderson; L G Wilke; C C Greenberg; Heather B Neuman Journal: Support Care Cancer Date: 2018-01-13 Impact factor: 3.603